AAAAAA
Results:
1-7
|
Results: 7
Authors:
Bonfanti, P
Landonio, S
Ricci, E
Martinelli, C
Fortuna, P
Faggion, I
Quirino, T
Citation: P. Bonfanti et al., Risk factors for hepatotoxicity in patients treated with highly active antiretroviral therapy, J ACQ IMM D, 27(3), 2001, pp. 316-318
Authors:
Bonfanti, P
Ricci, E
Landonio, S
Valsecchi, L
Timillero, L
Faggion, I
Quirino, T
Citation: P. Bonfanti et al., Predictors of protease inhibitor-associated adverse events, BIOMED PHAR, 55(6), 2001, pp. 321-323
Authors:
Bonfanti, P
Valsecchi, L
Parazzini, F
Carradori, S
Pusterla, L
Fortuna, P
Timillero, L
Alessi, F
Ghiselli, G
Gabbuti, A
Di Cintio, E
Martinelli, C
Faggion, I
Landonio, S
Quirino, T
Citation: P. Bonfanti et al., Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study, J ACQ IMM D, 23(3), 2000, pp. 236-245
Authors:
Quirino, T
Niero, F
Ricci, E
Pusterla, L
Carradori, S
Gabbuti, A
Iemoli, E
Landonio, S
Faggion, I
Bonfanti, P
Citation: T. Quirino et al., HAART tolerability: post-exposure prophylaxis in healthcare workers versustreatment in HIV-infected patients, ANTIVIR TH, 5(3), 2000, pp. 195-197
Authors:
Bonfanti, P
Pusterla, L
Parazzini, F
Libanore, M
Cagni, AE
Franzetti, M
Faggion, I
Landonio, S
Quirino, T
Citation: P. Bonfanti et al., The effectiveness of desensitization versus rechallenge treatment in HIV-positive patients with previous hypersensitivity to TMP-SMX: a randomized multicentric study, BIOMED PHAR, 54(1), 2000, pp. 45-49
Authors:
Bonfanti, P
Faggion, I
Catamancio, SL
Violin, M
Balotta, C
Rusconi, S
Citation: P. Bonfanti et al., Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase, ANTIM AG CH, 44(6), 2000, pp. 1767-1768
Authors:
Iemoli, E
Vivirito, MC
Coen, M
Faggion, I
Quirino, T
Citation: E. Iemoli et al., Anticonvulsant hypersensitivity syndrome due to carbamazepine, ALLERGY, 54(12), 1999, pp. 1329-1330
Risultati:
1-7
|